Saphenous Vein Graft (SVG) Stenosis Revascularization with Percutaneous Coronary Intervention (PCI)

Case Report


  • Amalia Nurjanah General practitioner, RSUD Abdoel Wahab Sjahranie, Samarinda, Indonesia
  • Wynne Putradana General Practitioner, RSUD Abdoel Wahab Sjahranie, Samarinda, Indonesia
  • Djoen Herdianto Intervention Cardiologist, RSUD Abdoel Wahab Sjahranie, Samarinda, Indonesia



Coronary artery bypass grafting, drug-eluting stent, percutaneous coronary intervention, saphenous vein graft stenosis


Coronary artery bypass grafting (CABG) is the most ideal and frequently performed procedure for multi-vascular coronary artery stenosis, but its long-term prognosis is unfavorable. A 64-year-old male with a history of coronary artery graft surgery seven years ago complained of recurrent chest pain radiating to the jaw, relieved by isosorbide dinitrate. Physical examination, electrocardiography, and echocardiography test results were within normal limits. Laboratory results showed critical blood urea nitrogen (BUN) values requiring hemodialysis, on angiographic examination showed stenosis in all grafted and native coronary arteries. The diagnoses were grade III coronary artery disease and renal failure. Percutaneous coronary intervention using a drug-eluting stent (DES) in the saphenous vein graft conduit of the right coronary artery was performed, along with dual antiplatelet agents, b-blockers, nitrates, and statins.


Download data is not yet available.


Paolo Weltert L, Audisio K, Bellisaro A, Bardi G, Flocco R, De Paulis R, et al. External stenting of vein grafts in coronary artery bypass grafting: interim results from a two centers prospective study. J Cardiothorac Surg. 2021 Apr;16(1):74.

Jannati M, Navaei M, Ronizi L. A comparative review of the outcomes of using arterial versus venous conduits in coronary artery bypass graft (CABG). J Fam Med Prim Care. 2019; 8(9): 2768.

Xenogiannis I, Zenati M, Bhatt DL, Rao S V, Rodés-Cabau J, Goldman S, et al. Saphenous vein graft failure: From pathophysiology to prevention and treatment strategies. Circulation 2021;144:728–45.

Valdes PJ, Dorosh J, Lin JC, Diaz MA. Vein graft stenosis. StatPearls [Internet]. 2022 Dec 9 [cited 2023 Jul 22]. Available from:

Raza S, Chang C, Deo SV, Sabik JF. Current role of saphenous vein graft in coronary artery bypass grafting. Indian J Thorac Cardiovasc Surg. 2018 Dec; 34(Suppl 3): 245–50.

Guida G, Ward AO, Bruno VD, George SJ, Caputo M, Angelini GD, et al. Saphenous vein graft disease, pathophysiology, prevention, and treatment. A review of the literature. J Card Surg. 2020 Jun;35(6):1314–21.

Sabik JF. Understanding saphenous vein graft patency. Circulation 2011 Jul 19;124(3):273–5.

Sardella G, Mancone M. Invasive functional test in patients with angina and suspected CAD: search more to learn more. J Am Coll Cardiol. 2018 Dec;72(23 Pt A):2856–8.

Kirtane AJ, Doshi D, Leon MB, Lasala JM, Ohman EM, O’Neill WW, et al. Treatment of higher-risk patients with an indication for revascularization. Circulation. 2016 Aug 2;134(5):422–31.

Han Y, Jing QM, Wang QC, Su Y Bin, Chen GJ. Percutaneous recanalization of total saphenous vein graft occlusion with excimer laser treatment. J Geriatr Cardiol. 2020;17(4):234.

Tsao CW, Aday AW, Almarzooq ZI, Alonso A, Beaton AZ, Bittencourt MS, et al. Heart disease and stroke statistics—2022 update: A report from the American Heart Association. Circulation 2022 Feb;145(8):E153–639.

Wilson SJ, Hanratty CG, Spence MS, Owens CG, Rigger J, Spratt JC, et al. Saphenous vein graft sacrifice following native vessel PCI is safe and associated with favourable longer-term outcomes. Cardiovasc Revasc Med. 2019 Dec;20(12):1048–52.

de Winter RW, Walsh SJ, Hanratty CG, Spratt JC, Sprengers RW, Twisk JW, et al. Percutaneous coronary intervention of native coronary artery versus saphenous vein graft in patients with prior coronary artery bypass graft surgery: Rationale and design of the multicenter, randomized PROCTOR trial. Am Heart J. 2023 Mar 1; 257: 20–9.

Brilakis ES, O’Donnell CI, Penny W, Armstrong EJ, Tsai T, Maddox TM, et al. Percutaneous coronary intervention in native coronary arteries versus bypass grafts in patients with prior coronary artery bypass graft surgery: Insights from the veterans affairs clinical assessment, reporting, and tracking program. JACC Cardiovasc Interv. 2016 May;9(9): 884–93.

Thomas A, Gitto M, Shah S, Saito Y, Tirziu D, Chieffo A, et al. Antiplatelet strategies following PCI: A review of trials informing current and future therapies. Journal of the Society for Cardiovascular Angiography & Interventions [Internet]. 2023 May 1 [cited 2023 Jul 22]; 2(3). Available from:

Wallentin L, Varenhorst C, James S, Erlinge D, Braun OÖ, Jakubowski JA, et al. Prasugrel achieves greater and faster P2Y12receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease. Eur Heart J. 2008 Jan; 29(1):21–30.

Valgimigli M, Bueno H, Byrne RA, Collet JP, Costa F, Jeppsson A, et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J [Internet]. 2018 Jan 14 [cited 2023 Aug 17]; 39(3): 213–54. Available from:

Levine GN, Bates ER, Bittl JA, Brindis RG, Fihn SD, Fleisher LA, et al. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: A report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines: An update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease, 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction, 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes, and 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery. Circulation 2016 Sep 6;134(10):e123–55.

Kulik A, Voisine P, Mathieu P, Masters RG, Mesana TG, Le May MR, et al. Statin therapy and saphenous vein graft disease after coronary bypass surgery: Analysis from the CASCADE randomized trial. Ann Thoracic Surg. 2011 Oct; 92(4):1284–91.

Zhao S, Chen Y, Zhu B, Wang J, Wei Z, Zou Y, et al. Percutaneous coronary intervention improves quality of life of patients with chronic total occlusion and low estimated glomerular filtration rate. Front Cardiovasc Med. 2022 Dec 21;9:1019688.

Skalsky K, Shiyovich A, Steinmetz T, Kornowski R. Chronic renal failure and cardiovascular disease: A comprehensive appraisal. J Clin Med. 2022 Mar;11(5):1335.

Redfors B, Généreux P, Witzenbichler B, McAndrew T, Diamond J, Huang X, et al. Percutaneous coronary intervention of saphenous vein graft. Circ Cardiovasc Interv [Internet]. 2017 May 1 [cited 2023 Jul 22];10(5). Available from:




How to Cite

Amalia Nurjanah, Wynne Putradana, & Djoen Herdianto. (2024). Saphenous Vein Graft (SVG) Stenosis Revascularization with Percutaneous Coronary Intervention (PCI): Case Report. Cermin Dunia Kedokteran, 51(6), 321–324.